FirmAtlas
Company handbook · BAX · Prepared by FirmAtlas · firmatlas.app · printed 2026-10-17
BAX · CIK 10456 · LATEST FILING: 10-Q JUN '26 · FILED JUL 30, 2026
Baxter International Inc.
$25.28
−0.48 (−1.86%)
Close, Oct 16, 2026 · 52-week $16–30
Last fiscal year
Baxter International Inc. reported revenue of $11.2B for the year ended Dec 31, 2025 (FY25), up 5.7% from FY24. Net loss was $957M, operating cash flow $845M and free cash flow $332M. Source: 10-K filed Feb 12, 2026.
Market cap
$13.0B
EV/EBITDA
30.4x
P/B
2.1
Div yield
0.16%
ROIC
−2.1%
Revenue 1Y
5.7%/yr
EPS 1Y
n/m
Shares 1Y
+0.6%
Loading chart…
Median
Daily closes, split-adjusted · ratios at each fiscal year end
Company
CEOAndrew P. Hider
HQDeerfield, IL
AuditorPricewaterhouseCoopers LLP
Employees37,500
Year endsDecember
Compounded growth & averages
10Y
5Y
3Y
TTM
Share price
−6.1%
−20.5%
−7.5%
10.1%
Upgrade to see 10 years
Share price: yearly compound rate of the traded close; the last column is the past year.
Where the cash went · FY24–FY25
$1.9B deployed
Capex
$959M
49.9%
Acquisitions
$23M
1.2%
Dividends
$938M
48.9%
Operating cash flow over the period: $1.9B. Total debt changed by −$901M. R&D of $1.1B is already inside operating costs.
Growth engines
How much of the profit growth came from new investment, and how much from running the business better.
Upgrade to see 10 years
Financials
Last 2 years · Upgrade to see 10 years · USD millions · each year opens its 10-K · change vs previous year
Last 4 quarters · USD millions · quarter-end month shown · change vs same quarter a year earlier
TTM = the last four quarters, to Jun '26. Balance-sheet rows show that latest quarter. “—” where the quarters do not add up to the annual figures. No TTM for cash: our quarterly rows do not hold short-term investments yet, and annual cash includes them.
Income
Revenue
10,636
11,244+5.7%
11,470
YoY
+5.7%
Gross profit
3,984
3,379−15.2%
3,450
Gross margin
37.5%
30.1%−7.4 pp
—
Operating income
14
(308)−2300.0%
(274)
Operating margin
0.1%
−2.7%−2.9 pp
—
EBITDA
1,011
673−33.4%
—
EBITDA margin
9.5%
6.0%−3.5 pp
—
Interest expense
408
290−28.9%
—
Interest coverage
2.48x
2.32x−0.16x
—
Net income
(649)
(957)n/m
(1,063)
YoY
n/m
Net margin
−6.1%
−8.5%−2.4 pp
—
EPS (diluted, $)
−1.27
−1.87n/m
−2.08
YoY
n/m
Balance sheet
Total assets
25,782
20,055−22.2%
19,791
Cash & short-term investments
1,766
1,968+11.4%
—
Accounts receivable
1,679
1,861+10.8%
—
Inventory
2,046
2,232+9.1%
—
Net PP&E
2,870
2,910+1.4%
—
Other assets
17,421
11,084−36.4%
—
Total liabilities
18,818
13,926−26.0%
13,585
Accounts payable
968
999+3.2%
—
Total debt
10,374
9,473−8.7%
0
Other liabilities
7,476
3,454−53.8%
—
Shareholders’ equity
6,964
6,129−12.0%
6,206
Total liabilities = total assets − shareholders’ equity, so it includes minority interest where a company has one.
Cash flow statement · as filed
Cash from operations
1,019
845−17.1%
1,319
Net income
(638)
(957)n/m
—
Depreciation & amortization
997
981−1.6%
—
Stock-based compensation
114
117+2.6%
—
Working capital & other
546
704+28.9%
—
Cash from investing
(626)
2,841n/m
—
Capex
(446)
(513)n/m
—
Acquisitions
(14)
(9)n/m
—
Investments sold / matured
34
0−100.0%
—
Other investing
(200)
3,363n/m
—
Cash from financing
(1,081)
(4,216)n/m
—
Debt raised
0
1,998n/m
—
Debt repaid
(2,657)
(5,489)n/m
—
Dividends
(590)
(348)n/m
—
Buybacks
0
—
—
Other financing
2,166
(377)−117.4%
—
Net change in cash
(784)
(446)n/m
—
Free cash flow (OCF − capex)
573
332−42.1%
—
Where the cash went
Operating cash flow
1,019
845−17.1%
1,319
Reinvested in the business
460
522+13.5%
—
% of operating cash flow
45.1%
61.8%
Capex
446
513+15.0%
—
Acquisitions
14
9−35.7%
—
R&D (memo, already in costs)
590
518−12.2%
—
Free cash flow
573
332−42.1%
—
YoY
−42.1%
Returned to shareholders
590
348−41.0%
—
% of free cash flow
103.0%
104.8%
Dividends
590
348−41.0%
—
Buybacks
0
—
—
Change in total debt
—
(901)
—
Cash left over
—
(926)
—
Owner earnings
—
(826)
—
Owner earnings margin
—
−7.3%
—
Returns & ratios
ROIC (all capital)
0.1%
−2.1%−2.2 pp
—
ROIC (operating)
0.2%
−5.3%−5.5 pp
—
Net debt / EBITDA
8.51x
11.15x+2.64x
—
Debt / equity
1.49x
1.55x+0.06x
—
Cash conversion cycle (days)
117
118+1 d
—
ROE
−9.3%
−15.6%−6.3 pp
—
ROA
−2.5%
−4.8%−2.3 pp
—
ROCE
0.1%
−1.8%−1.9 pp
—
NOPAT
14
(308)−2300.0%
—
Invested capital (operating)
5,627
6,004+6.7%
—
Invested capital (all)
15,572
13,634−12.4%
—
Reinvestment rate
—
−122.4%
—
Debtor days
58
60+3 d
—
Inventory days
112
104−9 d
—
Days payable
53
46−7 d
—
Net debt is 11.2x EBITDA (FY25).
Income
Sep '25
Dec '25
Mar '26
Jun '26
Revenue
2,835
2,974
2,701
2,960
vs year-ago quarter
Gross profit
950
577
891
1,032
Gross margin
33.5%
19.4%
33.0%
34.9%
Operating income
172
(729)
66
217
Net income
(46)
(1,128)
(15)
126
vs year-ago quarter
Net margin
−1.6%
−37.9%
−0.6%
4.3%
EPS (diluted, $)
−0.09
−2.20
−0.03
0.24
vs year-ago quarter
Balance sheet
Sep '25
Dec '25
Mar '26
Jun '26
Total assets
21,067
20,055
19,846
19,791
Cash & equivalents
1,728
1,968
2,019
2,150
Total debt
4
9,473
0
0
Shareholders’ equity
7,241
6,129
6,043
6,206
Cash flow
Sep '25
Dec '25
Mar '26
Jun '26
Operating cash flow
237
584
213
285